Pharmaceuticals company Ami Organics announced Q4FY25 results Revenue from operations for Q4FY25 grew by 37.1% YoY to Rs 3,085 million. The gross margin for the quarter improved to 47.3% up 734 bps YoY and 108 bps QoQ. EBITDA for the quarter came at Rs 850 million up 96.8% YoY compared to Rs 432 million in Q4FY24. EBITDA margin for the quarter was at 27.5% as compared to 19.2% in Q4FY24. PAT for the quarter was Rs 627 million up 144.2% as compared to PAT of Rs 257 million in Q4FY24. The PAT margin for the quarter was at 20.3% up 892 bps YoY and 380 bps QoQ. Export for the quarter at 74%; domestic business at 26%. Naresh Patel, Executive Chairman & Managing Director, Ami Organics, said: “I am delighted to share that FY25 was a transformative year for Ami Organics, as we proudly surpassed Rs 1,000 crore in revenue a remarkable milestone. This achievement reflects the unwavering dedication of our employees and the invaluable support of our stakeholders, including customers, suppliers, shareholders and all other stakeholders. We extend our heartfelt gratitude for their contributions. As we embark on an exciting new phase of growth, we are embracing a bold, future-focused brand identity that aligns with our vision to lead as a diversified specialty chemicals company, serving next-generation industries with a steadfast commitment to sustainability. To reflect this ambition, we are transitioning from “Ami Organics Limited” to “Acutaas Chemicals Limited”. Looking ahead to FY26, we anticipate robust growth across all business segments, driving our confidence in achieving 25% revenue growth.” Result PDF